rs2227568

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002658.6(PLAU):​c.822C>T​(p.Asn274Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,613,432 control chromosomes in the GnomAD database, including 21,791 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1608 hom., cov: 33)
Exomes 𝑓: 0.16 ( 20183 hom. )

Consequence

PLAU
NM_002658.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.09

Publications

19 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 10-73914121-C-T is Benign according to our data. Variant chr10-73914121-C-T is described in ClinVar as Benign. ClinVar VariationId is 300756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLAUNM_002658.6 linkc.822C>T p.Asn274Asn synonymous_variant Exon 8 of 11 ENST00000372764.4 NP_002649.2 P00749-1A0A024QZM9Q59GZ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLAUENST00000372764.4 linkc.822C>T p.Asn274Asn synonymous_variant Exon 8 of 11 1 NM_002658.6 ENSP00000361850.3 P00749-1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19827
AN:
152132
Hom.:
1609
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0619
Gnomad AMI
AF:
0.202
Gnomad AMR
AF:
0.0899
Gnomad ASJ
AF:
0.263
Gnomad EAS
AF:
0.307
Gnomad SAS
AF:
0.231
Gnomad FIN
AF:
0.142
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.124
GnomAD2 exomes
AF:
0.166
AC:
41745
AN:
250806
AF XY:
0.174
show subpopulations
Gnomad AFR exome
AF:
0.0655
Gnomad AMR exome
AF:
0.0969
Gnomad ASJ exome
AF:
0.268
Gnomad EAS exome
AF:
0.312
Gnomad FIN exome
AF:
0.145
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.165
GnomAD4 exome
AF:
0.159
AC:
232687
AN:
1461182
Hom.:
20183
Cov.:
34
AF XY:
0.163
AC XY:
118366
AN XY:
726930
show subpopulations
African (AFR)
AF:
0.0612
AC:
2047
AN:
33472
American (AMR)
AF:
0.0956
AC:
4273
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
7039
AN:
26124
East Asian (EAS)
AF:
0.321
AC:
12736
AN:
39680
South Asian (SAS)
AF:
0.240
AC:
20733
AN:
86216
European-Finnish (FIN)
AF:
0.152
AC:
8129
AN:
53306
Middle Eastern (MID)
AF:
0.174
AC:
1000
AN:
5744
European-Non Finnish (NFE)
AF:
0.150
AC:
166738
AN:
1111580
Other (OTH)
AF:
0.166
AC:
9992
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
9449
18898
28346
37795
47244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6124
12248
18372
24496
30620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19826
AN:
152250
Hom.:
1608
Cov.:
33
AF XY:
0.130
AC XY:
9701
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0618
AC:
2567
AN:
41558
American (AMR)
AF:
0.0899
AC:
1375
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
914
AN:
3472
East Asian (EAS)
AF:
0.308
AC:
1591
AN:
5164
South Asian (SAS)
AF:
0.231
AC:
1116
AN:
4824
European-Finnish (FIN)
AF:
0.142
AC:
1511
AN:
10612
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.151
AC:
10259
AN:
68008
Other (OTH)
AF:
0.122
AC:
257
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
886
1772
2658
3544
4430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
2902
Bravo
AF:
0.125
Asia WGS
AF:
0.242
AC:
843
AN:
3478
EpiCase
AF:
0.153
EpiControl
AF:
0.152

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Quebec platelet disorder Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
0.19
DANN
Benign
0.90
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227568; hg19: chr10-75673879; COSMIC: COSV65641301; COSMIC: COSV65641301; API